Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
245.72
-0.31 (-0.13%)
At close: Nov 13, 2026, 4:00 PM EST
246.75
+1.03 (0.42%)
After-hours: Nov 13, 2026, 7:30 PM EST
Glaukos Revenue
Glaukos had revenue of $211.03M in the quarter ending September 30, 2026, with 58.03% growth. This brings the company's total for the last twelve months to $690.33M, up 46.94% year-over-year. In the year 2025, Glaukos had annual revenue of $507.44M with 32.33% growth. That makes Glaukos the 9,475th largest company in the world by revenue and 2,077th in the United States.
Revenue (ttm)
$690.33M
Revenue Growth
+46.94%
P/S Ratio
21.06
Revenue / Employee
$631,016
Employees
1,094
Market Cap
14.54B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Glaukos breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 507.44M | 123.96M | 32.33% |
| Dec 31, 2024 | 383.48M | 68.77M | 21.85% |
| Dec 31, 2023 | 314.71M | 31.85M | 11.26% |
| Dec 31, 2022 | 282.86M | -11.15M | -3.79% |
| Dec 31, 2021 | 294.01M | 69.05M | 30.70% |
| Dec 31, 2020 | 224.96M | -12.03M | -5.07% |
| Dec 31, 2019 | 236.98M | 55.71M | 30.73% |
| Dec 31, 2018 | 181.28M | 22.02M | 13.83% |
| Dec 31, 2017 | 159.25M | 44.86M | 39.21% |
| Dec 31, 2016 | 114.40M | 42.70M | 59.55% |
| Dec 31, 2015 | 71.70M | 26.11M | 57.28% |
| Dec 31, 2014 | 45.59M | 24.64M | 117.64% |
| Dec 31, 2013 | 20.95M | 18.52M | 762.33% |
| Dec 31, 2012 | 2.43M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.16B |
| Zimmer Biomet Holdings | 8.57B |
| Smith & Nephew | 6.30B |
| STERIS | 6.17B |
| Bruker | 3.51B |
| Insulet | 3.19B |
| Globus Medical | 3.14B |
| Bio-Rad Laboratories | 2.59B |
GKOS News
- 5 days ago - Glaukos Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 12 days ago - Glaukos Announces Participation in Upcoming Investor Conferences - Business Wire
- 12 days ago - Glaukos Slides: Investor presentation - Filings
- 16 days ago - Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 16 days ago - Glaukos to replace Okta in S&P 400 at open on 11/4 - TheFly
- 16 days ago - McGrath RentCorp to replace Glaukos in S&P 600 at open on 11/4 - TheFly
- 17 days ago - Glaukos rises 32.2% - TheFly
- 17 days ago - Glaukos rises 27.3% - TheFly